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Background: Existing systematic reviews aimed at comparing effectiveness of childhood obesity treatment interventions
are limited by a lack of quality in the conduct and reporting of trials in this area. This study aimed to identify the number
and types of primary and secondary outcomes used within trials of childhood obesity treatments and to determine the
degree to which these trials correctly report their use of outcome measures. A systematic literature review was conducted
to identify phase II (i.e. pilot and feasibility studies) and phase III (e.g. determining effectiveness) trials of childhood obesity
treatments across 11 databases. Data were extracted from eligible manuscripts pertaining to the number and type of
outcome measures used, in addition to details of citations provided for these measures.
Results: 145 different outcome measures were reported to be used within 200 identified eligible trial manuscripts.
Citations were provided to indicate the provenance for 417 measures, but only 13% of these were correctly linked to
papers describing the development and/or evaluation of measures.
Conclusions: This study identified inconsistencies and inaccuracies in the use and reporting of outcome measures
used by eligible trials. Researchers in this area are urged to consider guidelines such as CONSORT and the National
Obesity Observatory Standard Evaluation Framework in the design and reporting of future trials.
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Many interventions to treat obesity are aimed at chil-
dren, but there remains a lack of high quality evidence
on effective childhood obesity interventions in the litera-
ture [1]. Existing systematic reviews aimed at comparing
effectiveness of intervention programmes (particularly
those conducting meta-analysis) are hampered by a lack
of quality in the conduct and reporting of trials in this
area. There has been some attenuation in the rising rates
of childhood obesity in recent years, and it is therefore
probable that many attempts to treat obesity in children
have been of some success [2]. The problem, therefore,
may lie in the methods used to evaluate and report
interventions.
The degree to which weight management leads to im-
provements in a child’s health is reflected by measuring* Correspondence: m.j.bryant@leeds.ac.uk
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unless otherwise stated.change in outcomes in clinical trials. Outcomes either
directly measure a trial primary outcome, (i.e. primary
outcome of weight loss); or assess proximal/secondary
outcomes (e.g. change in diet) that impact on the pri-
mary outcome. In the design phase of a trial, choosing
the appropriate outcomes is essential. Use of inappropri-
ate outcomes will result in data that are inaccurate or
biased and that do not indicate the effectiveness of an
intervention. Moreover, collection of data using poorly
chosen outcomes is a waste of resources, both for the re-
searchers and participants involved in the trial [3]. In-
appropriate selection of outcomes in childhood obesity
research is likely due to the uncertainty about which out-
come domains are most relevant to children and their
families [4]. Furthermore, there has been no guidance on
which outcome measures are valid and reliable for use.
Guidance tools are available to facilitate the design of
high quality research, including the Medical Research
Council guidance for the evaluation of complex inter-
ventions and, more specifically, the National ObesityLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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for childhood obesity evaluation (http://www.noo.org.uk/
core/SEF) [5]. The latter (commissioned by the UK
Department of Health) was produced with guidance
from prominent obesity researchers to aid clinicians in
their evaluation of childhood obesity programmes. It
now stands as a grounded tool to enable consistency
with research design and includes items for guidance
with data collection and dissemination (e.g. essential infor-
mation to describe the intervention, participant demo-
graphics, essential and desirable outcome measures (e.g.
adiposity), process measurement; and analysis and inter-
pretation) [5]. The primary audience for the NOO SEF
was those evaluating public health obesity programmes.
However, much of the advice is of relevance to researchers
conducting trial evaluations. Recommended outcomes
with the NOO SEF are listed and described as ‘essential’
or ‘desirable’. This resembles the output of a core outcome
set, though the inclusion of each outcome has not been
based on formal consensus methodologies, such as
those described by ‘COMET’ (Core Outcome Measures
in Effectiveness Trials). Further, many of the recommenda-
tions are not ‘outcomes’ but include guidance on the col-
lection of demographic information, process evaluation,
and analysis and dissemination. Core outcome sets are a
minimum set of outcomes that should be measured and
reported within trials or other forms of research for a spe-
cific condition (http://www.comet-initiative.org/). The use
of core outcome sets permits comparisons between trials
that are agreed upon by experts within each disease area.
As present, there is not a core outcome set for obesity re-
search; partly because of the complexity and variability in
intervention targets (requiring potentially different out-
comes). The NOO SEF therefore stands as a guide, rather
than a minimum set of outcomes. Importantly, the NOO
SEF does not provide advice or details of outcome mea-
sures that should be used within each outcome domain
that it recommends.
This paper aimed to identify primary and secondary
outcomes used within trials of childhood obesity treat-
ments and to determine the degree to which these trials
correctly report their use of outcome measures. To our
knowledge, there have been no previous publications de-
scribing this methodology to highlight issues in the use
and reporting of outcome measures within childhood
obesity trials in order to make recommendations for
optimising the design and dissemination of future trials
in this area.
Methods
A systematic literature review was conducted as part of
a study aiming to develop a framework of recommended
outcome measures for use in trials of obesity treatments
(HTA 07/127/09 [6,7]). Included manuscripts were thosedescribing randomised controlled trials, pilot and feasi-
bility studies of childhood obesity treatment evaluation
studies (with the intent of identifying outcome measures
(and corresponding citations) already used in trials). The
search was conducted from August 2011 to October 2011
in 11 databases including: MEDLINE, MEDLINE in process,
EMBASE, PsycINFO, HMIC, AMED, Global Health,
Maternity and Infant Care (all Ovid); Cinahl (EbscoHost);
Science Citation Index (WoS); and the Cochrane Library
(Wiley) from the date of inception, with no language
restrictions.
Search strategy
Search concepts included obesity terms AND child terms
AND evaluative studies terms. The evaluative studies
search consisted of focused ‘textword’ and subject heading
searches (MeSH: exp clinical trial/, or evaluation studies/
or meta-analysis/ or validation studies/, Randomised
Controlled Trials as Topic/) (See Additional file 1). Child
obesity terms identified in the Cochrane review [8] were
also incorporated where appropriate. Unpublished literature
was also obtained by searching a range of relevant databases
including Inside Conferences, Systems for Information
in Grey Literature (SIGLE), Web of Science Conference
Proceedings Citation Index- Science (Thomson) and
ClinicalTrials.gov. The same eligibility criteria were ap-
plied for each of these additional sources.
Eligibility criteria
Only manuscripts describing primary research of obesity
treatment intervention evaluation studies were eligible,
including: RCTs, pilot studies and feasibility studies
(with the intention of carrying out RCT). Within trials
of obesity treatment interventions, phase II trials are
usually either pilot or feasibility studies which evaluate
the feasibility of the intervention process and/or the trial
procedures. Feasibility studies test out individual compo-
nents of a future trial and do not have to be randomised
(though often are). Pilot studies are a small version of a
phase III trial and can be internal (i.e. first part of a phase
III, in which case the data may be used for the phase III)
or external (i.e. conducted separate to the phase III). Phase
III trials are studies that tell us whether or not interven-
tions are efficacious (e.g. blinded drug interventions) or
effective (e.g. lifestyle interventions) [9]. Inclusion of both
treatment and prevention interventions for this study
was not considered to be feasible following a scoping
exercise of the number of potential papers. Prevention
interventions also have a wider scope and would in-
clude more environmental and political outcomes,
which we believe warranted a separate framework. Al-
though there is scope to use the guidance when
choosing outcome measures for prevention trials, con-
sideration for their recommendation (inclusion to the
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trials (and has considered their historical use in previ-
ous treatment intervention evaluations).
Quality assessment was not an inclusion criterion, as
the aim was not to ascertain evidence on intervention
effectiveness. The included samples were any childhood
study population (equal to or less than 18 years at base-
line). Studies with special populations (i.e. those with a
cause of obesity such as Prader Willi) were included. In
terms of intervention, we included any type of intervention
to treat obesity, including drug and surgery interventions.
These are defined according to categories of strategies set a
Cochrane Review of childhood obesity treatment trials [8]
as ‘lifestyle’ (dietary, physical activity and/or behavioural
therapy interventions), Drug (e.g. orlistat, metformin, sibu-
tramine, rimonabant) and surgical interventions.
All studies had to have obesity reduction as a primary
outcome and a list of eligible measures was generated to
comply with this criteria. Examples included: Body mass
index (BMI), Waist circumference, Skin fold thickness,
Dual energy X-ray absorptiometry (DXA), Bioelectrical
Impedance (BIA) etc. Included secondary outcomes were:
diet, eating behaviour, physical activity, sedentary behav-
iour/time, fitness, psychological well-being, health related
quality of life, environment and physiology. Similar to pri-
mary outcome measures, another list of all potential types
of outcome measures was generated for each outcome
domain.
Excluded manuscripts were those: describing studies
without a primary outcome of obesity reduction such as
weight loss, BMI or adiposity reduction; with a second-
ary aim of obesity reduction (e.g. those with a primary
aim to control diabetes); providing details of outcome
measures for adults (or childhood outcomes are not re-
ported separately); obesity prevention studies (or de-
signs other than those listed in the inclusion criteria,
including letters, editorials, commentaries, dissertation,
books, erratum, notes, introductory, conference proceed-
ings, meeting abstracts and case reports); general reviews
or guidelines (unless specifically about the evaluation of
childhood obesity treatment interventions (e.g. Luttikhuis
et al. [8] in which citations were searched); papers without
sufficient information to determine eligibility (where au-
thor cannot provide missing information); those not spe-
cifically focusing on all obese subjects for intervention;
maintenance studies that were retrospective to studies
previously carried out; and phase 1 testing for drug trials
(i.e. safety, tolerance, effect).
Data extraction
A description of papers fulfilling the eligibility criteria
was entered onto a trial specific pre-prepared standar-
dised data-extraction form. Three versions of paper
based forms were initially piloted until a final form wascreated and incorporated into the ‘Bristol Online Survey’
(BOS http://www.survey.bris.ac.uk). This enabled reloca-
tion of all data into an excel database. In addition to in-
formation on the trial (sample characteristics, type of
intervention, study design), detailed data were gathered
on the use of outcome measures, including the outcome
domain (e.g. diet), the type of outcome measure (e.g. re-
call questionnaire) and the provenance of each measure
(i.e. linked citations). All citations linked to outcome
measures were then individually sourced.
Results
A total of 14,419 manuscripts were identified across all
search engines. Screening for eligibility at both the title
and abstract stage and the full paper review resulted in the
inclusion of 200 trial manuscripts (Figure 1) (References
in Additional file 2). The majority (156) described a phase
III evaluation of a childhood obesity treatment (i.e. a
trial describing the effectiveness of the intervention).
Nine manuscripts described a feasibility study, 30 de-
scribed a pilot study and 9 manuscripts were protocol
papers for future RCTs. Publication dates ranged from
1960 to 2012 and included sample sizes ranging from 8
[10] to 2112 [11].
Most studies evaluated a lifestyle intervention (Additional
file 3 references 3-4, 14-16, 20, 22-23, 26-27, 29, 32, 38, 41,
45-48, 51-53, 56-59, 62, 64-66, 72, 74, 77, 80, 83, 86, 88-91,
94, 98, 100, 101, 103-105, 107, 109-111, 113, 116, 126, 128,
129, 131-135, 141, 145, 147, 149, 151-153, 157-159,
161-163, 165, 168, 169, 171, 173, 175, 178, 182-187,189,
190-193, 198, 200), but there were also evaluations of
cognitive interventions, drug and surgical interventions,
drug/surgical interventions combined with lifestyle change
and those that focused on reducing sedentary behaviours.
Figure 2 shows the different types of primary outcome
measures used by eligible trials. The most common pri-
mary outcome was BMI (including those deriving BMI-
SDS or % BMI). However, measurement of weight was
also popular, with 37 evaluations assessing absolute weight
or percentage weight change as the primary outcome.
The most common secondary outcomes were diet, with
82 (41%) of trials including a dietary assessment measure.
Of these, 22 different types of dietary assessment methods
were used, including 16 different types of food frequency
questionnaires, diaries, recalls, direction observation and
biomarkers. Physiological outcomes were popular, with 47
(94%) including physiological outcomes such as blood
pressure, insulin or blood lipids. Sixty eight (34%) studies
included a measure of physical activity, with the most
popular measures being activity recalls and objective
measures (e.g. accelerometers or pedometers). Seventy
(35%) trials included measures of one or more of 17
different questionnaires to evaluate psychological well-
being, measuring a variety of concepts including self-
Systematic review
Childhood obesity treatment trials
N=14,419
Cited outcome measures used
N=417







Excluded cited methodology papers
N=361 for not meeting criteria 
Excluded at title and abstract N=12,973
Excluded at full text screening N=1,246
Figure 1 Summary of study selection and exclusion.
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http://www.biomedcentral.com/2052-9538/1/1/25esteem, depression and body image. Other secondary out-
comes (eating behaviours, health related quality of life, fit-
ness, sedentary behaviour, environment) were used less
frequently (Figure 3). A detailed description of each of
these measures, including the method of administration,
methods of development and psychometric evaluation is
available elsewhere [7].Figure 2 Frequency (%) of primary outcome measures used in
childhood obesity treatment trials.Across all 200 trial manuscripts, there were 417 cita-
tions linked to 145 different primary and secondary out-
come measures with the aim to report the origins
(including development and/or evaluation) of these mea-
sures. However, only 56 (13%) of these citations referred
to manuscripts that actually described the development
and/or evaluation of the outcome measures, with correct
citations reported in 46 out of 200 trial manuscripts.
This discrepancy in numbers was generated by trials pa-
pers that correctly provided for some citations, but notFigure 3 Frequency (%) of childhood obesity treatment trials
using each type of secondary outcome.
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tations were linked to the majority of outcome measures;
most commonly linking to a previous study that had
used the same measure.
The number of secondary outcomes reported to be
used ranged from 0-8, with an average of 2 used across
all trials. It is important to note that this study only
gathered data on secondary outcomes from 9 outcome
domains (diet, eating behaviour, physical activity, seden-
tary behaviour/time, fitness, psychological well- being,
health related quality of life, environment and physi-
ology) and additional outcomes in other domains (such
as parenting styles) were not recorded. Inconsistencies
were found in the choice of outcome measures across
trials, with a great variability in the types of outcome
measures used within each outcome domain (Figure 4).
For example, 22 different measures were used to assess
diet across the 82 trials that included this outcome. For
measurement of physical activity, 32 different types of
measurement tools were used across the 68 studies re-
ported to collect physical activity data. This pattern was
consistent across all outcome domains, including meas-
urement of health related quality of life, in which 11 dif-
ferent questionnaires were reported to be used across
the 17 trials reported to measure this outcome.
Discussion
This study identified inconsistencies and inaccuracies in
the use and reporting of outcome measures used by eli-
gible trials. It is likely that inconsistencies in the use of
outcome measures relates to the specific requirements
of each study (e.g. use of measures that are specific toFigure 4 Number of different types of measures used within
outcome domains/number of trials reporting assessing these
outcomes (e.g. of the 82 trials measuring diet, 18 different
types of diet assessment measurement tools were used).age and ethnicity of the sample). However, even taking
this into account, there were a great number of outcome
measures used which had similar characteristics. In
terms of reporting, only 13% of citations for outcome
measures used were correctly linked to a manuscript de-
scribing the development and/or evaluation of that
measure. A majority of inaccurate citations were linked to
previous trials also using the measure. The variation in
the use of appropriate outcome measures for the reliable
and valid assessment of childhood obesity interventions
means that comparisons between interventions are conse-
quently difficult, partly because of a shortage of validated
outcome measures available, but also because the selected
outcome measures differ between studies. Consequently,
it is a challenge to identify which interventions are the
most effective. Such a lack of consistency and inadequacy
impedes the progress of childhood obesity research.
When designing trials, there is always a danger of in-
cluding outcomes that are not relevant or necessary to
the research, particularly in large teams with varied in-
terests. This does not appear to have happened in the
200 included trials here, with an average of 2 secondary
outcomes reported per trial. However, this is likely to be
an underestimation of the actual number of outcomes
measured, as we only recorded outcomes within 9 out-
come domains. Additionally, some trials included mul-
tiple outcome measures for the same outcome. Lastly,
there is potential for some reporting bias here, given the
other observed inaccuracies in reporting, with some out-
comes not reported (especially those generating poor or
null findings).
However, discrepancies also arise owing to the large
availability of differing measures, and combined witha
lack of agreement of which measures are most valid, re-
liable and feasible for use. This study was conducted as
part of a study aiming to develop a framework of recom-
mended outcome measures (the Childhood obesity Out-
comes Review (CoOR Framework) for use in trials of
obesity treatments aimed at reducing such inconsisten-
cies (HTA 09/127/07). This framework includes 52 out-
come measures across 10 outcome domains (2 primary
and 50 secondary), which are recommended for use in
childhood obesity treatment evaluations [6,7]. Manu-
scripts identified here were supplemented by additional
manuscripts describing the development and/or evaluation
of outcome measures from a specific search of outcome
measures and resulted in the combined identification of
379 eligible manuscripts; describing 180 outcome mea-
sures. These outcome measures were appraised for quality
using international guidelines [12,13], followed by expert
agreement to enable the production of a framework of rec-
ommended 2 primary and 50 validated secondary outcome
measures within 10 outcome domains for use in childhood
obesity treatment evaluations (HTA 09/127/07 [6,7]).
Bryant et al. BMC Obesity 2014, 1:25 Page 6 of 7
http://www.biomedcentral.com/2052-9538/1/1/25When choosing measures, researchers should first
consider which (if any) secondary outcome domains are
most closely aligned to the targets of the intervention
under investigation; including, those that are expected to
change, those that are expected to mediate this change
(if appropriate); and any that may indicate an adverse
event (if appropriate). Any selected measure needs to be
aligned to the intervention targets, be developed for use
in a similar population and be feasible to implement. In
deciding the similarity between populations, validation
of a measure is only really relevant to the population
that it was evaluated in and researchers should make in-
formed decisions whether the characteristics of their
populations are sufficiently close to the population in
which the tool was developed.
Inaccuracies in reporting impact substantially on the as-
sessment of the quality, and therefore, the efficacy/effect-
iveness of trials through use of a tool in inappropropriate
populations or the use of tools with inadequate evidence
of validation. To reduce such errors, the CONSORT
(Consolidated Standards of Reporting Trials) statement
was published in 1996 with the aim of alleviating prob-
lems of inadequate reporting [14]. This statement com-
promises a 25-item checklist of which, Item 6a states that
‘All outcome measures, whether primary or secondary,
should be identified and completely defined’. Additionally,
this states that ‘Authors should indicate the provenance
and properties of scales’. Thirty eight of the 200 (19%) eli-
gible trial manuscripts were published before the release
of CONSORT. Of these, only 1 provided at least 1 correct
citation for included outcome measures. Of the 154 trials
providing incorrect citations for their outcomes, 37 (25%)
were published before 1996. This may demonstrate an im-
portant impact of the CONSORT statement, though this
study was not set up to assess the impact of CONSORT
and differences in reporting may relate to other factors.
Importantly, 117 of the trial manuscripts which had incor-
rect citations were published after 1996, highlighting con-
tinued issues with reporting of trials evaluating childhood
obesity treatment interventions.
Conclusion
It is imperative that researchers choose appropriate and
valid outcomes and measures in their evaluation of
childhood obesity programmes. This will support the ro-
bust development of evidence-base in this area and will
enable future assessment of the most effective ap-
proaches through meta-analysis. When selecting out-
comes, researchers should utilise tools such as the
Standard Evaluation Framework [5] and the CoOR
Framework [6,7] and consideration should carefully bal-
ance the scientific need of measurement against practi-
calities of assessment. Importantly, the selection of
outcomes should not be dictated by what is deemed to beinteresting, but rather by an a-prior plan of investigation.
Once conducted, it is then essential that optimal impact is
gained through correct reporting standards using guid-
ance from the CONSORT statement [14]. This will facili-
tate improved appraisal of trials, enable clear
comparisons between them and will reduce presenta-
tion of biased estimates of the benefits of interventions
under investigation [14]. In addition to aiding appraisal
of trials, the correct use and reporting of data from out-
come measures will reduce waste related to the collec-
tion of poor data, both for the researchers and
participants involved in the trials. Over-use of outcome
measures without a pre-determined plan of evaluation
is unethical and wasteful. Use of incorrect outcomes is
similarly wasteful and importantly, does not answer the
research question. Presentation of results from inappro-
priate outcomes is therefore misleading and biases the evi-
dence base. Rigour in outcome selection and reporting is
essential in effectively moving forward obesity research
which evaluates interventions in order to produce a truly
evidence-base of what is and is not effective.
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